BioVaxys Technology Corp is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields... Show more
Industry Biotechnology
A.I.dvisor tells us that BVAXF and BLUE have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and BLUE's prices will move in lockstep.
| Ticker / NAME | Correlation To BVAXF | 1D Price Change % | ||
|---|---|---|---|---|
| BVAXF | 100% | +9.15% | ||
| BLUE - BVAXF | 27% Poorly correlated | -0.40% | ||
| APLM - BVAXF | 27% Poorly correlated | +1.14% | ||
| RVMD - BVAXF | 25% Poorly correlated | +2.04% | ||
| SPHDF - BVAXF | 25% Poorly correlated | -7.23% | ||
| WVE - BVAXF | 23% Poorly correlated | +1.85% | ||
More | ||||